Default: Cancer Cytopathology

ISSN: 1934-662X

Journal Home

Journal Guideline

Cancer Cytopathology Q2 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Cytopathology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 61. It has a price of 2100 €. It has a best quartile of Q2.

Cancer Cytopathology focuses its scope in these topics and keywords: methods, cytology, liquidbased, dual, human, women, conventional, unsatisfactory, papanicolaou, pinkaki, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2100 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Cancer Cytopathology

-

SJR Impact factor

61

H Index

132

Total Docs (Last Year)

369

Total Docs (3 years)

3358

Total Refs

1222

Total Cites (3 years)

249

Citable Docs (3 years)

3.28

Cites/Doc (2 years)

25.44

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


methods, cytology, liquidbased, dual, human, women, conventional, unsatisfactory, papanicolaou, pinkaki, transitioning, fluorescence, lesioneffects, kidney, immunostaining, highrisk, followup, donationcombined, fish, easier, detectionevaluation, detection, application, cytologycomputerized, cytologic, cytodiagnosis, comparison, aptima,



Best articles by citations

Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis

View more

Thyroid FNA: Is cytopathologist review of ultrasound features useful?

View more

Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (>1.0 cm) that were not targeted

View more

Thyroid FNA: New classifications and new interpretations

View more

The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions

View more

The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio

View more

Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors

View more

Synovial sarcoma: Diagnosis on fine-needle aspiration by morphology and molecular analysis

View more

Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution

View more

Rapid on-site evaluation for endoscopic ultrasound-guided fine-needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures

View more

The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions

View more

Molecular testing of cytology specimens: Are we ready for the new era?

View more
SHOW MORE ARTICLES

Fine-needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocytosis

View more

The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System

View more

Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?

View more

Application of a machine learning algorithm to predict malignancy in thyroid cytopathology

View more

Toward a multimodal cell analysis of brush biopsies for the early detection of oral cancer

View more

Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma

View more

The role of systematic review and meta-analysis in modern cytopathology

View more

Is the cytodiagnosis of mesothelioma any easier these days?

View more

Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity

View more

Color blindness in the medical workplace

View more

Cytologic and molecular diagnosis of thyroid cancers

View more

Cervical and anal cancer prevention in jails and prisons: "A missed opportunity"

View more

FAQS